Меню
Идёт набор NCT06861868

Brain and Behavior Influences on Obesity Development From Infancy Through Childhood

Без фазы С лечением Obesity and Overweight

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: fMRI cue reactivity task, fMRI go no go task, Ad libitum meal test, Eating in the absence of hunger test.
Кому может быть актуально
Состояния в реестре: Obesity and Overweight. Базовые параметры: 7 лет — 12 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Early Brain Development and Child Nutrition and Obesity

Обзор

The investigators project, RESONATE, aims to investigate why some children develop obesity. To do this it uses data on eating and eating-related behaviors, genetic and environmental factors, and brain structure and function. This data is collected in a sub-sample of RESONANCE, a large study of families of children from infancy through childhood. The results will lay foundations for the development of early interventions to prevent or treat obesity.

Подробное описание

Obesity risk shows individual variation such that some children are more likely than others to gain excess weight. One potential reason is that, due to genetic and environmental factors, individuals vary in appetitive behaviors that drive food intake and weight. However, the neurodevelopmental mechanisms underpinning variation in appetite and weight, and effects of risk and protective factors on those outcomes, are not understood. Preliminary data from RESONANCE, the investigators large MRI cohort, suggests obesity risk factors such as maternal pre-pregnancy obesity and obesity-associated genetic variants are associated with not just heightened parent-reported child appetite and adiposity, but with altered patterns of brain structure development from infancy through early childhood. However the relevance of these findings to appetitive behaviors and development of obesity in middle childhood is unknown. This is important because obesity rates and metabolic complications increase through development, adiposity and eating habits measured in later childhood track into adulthood, and obesity is harder to treat later in development, making middle childhood a key stage for capturing outcomes with relevance for lifetime metabolic health. Further, although functional magnetic resonance imaging (MRI) studies have identified altered patterns of activation in brain appetite circuits in association with pediatric obesity and early risk factors for obesity, the predictors of altered functioning of brain appetite circuits in middle childhood are unknown. Identifying the patterns of brain development that predict obesity-promoting behaviors and brain functioning in middle childhood is essential to understand the neural mechanisms by which early obesity risk factors drive excess intake and obesity, and may help pinpoint neurobehavioral targets for early obesity prevention. Finally, although preclinical research and MRI studies of children under 9 years of age support that hypothalamic gliosis, a cellular inflammatory response, plays a role in obesity pathogenesis, it is unclear whether it occurs or impacts appetite in earlier life. For the proposed study, RESONATE, the investigators will address the above research gaps by extending the RESONANCE study to administer meal tests, behavioral and functional magnetic resonance imaging (fMRI) tasks assessing food and non-food reward and cognitive control, and weight/ adiposity measures in middle childhood, and examining hypothalamic gliosis, in a sub-sample of RESONANCE children. By combining this data with extant MRI data and extant or newly-collected data on obesity risk and protective factors, the investigators will test a multi-faceted hypothesis that prenatal, genetic and postnatal factors lead to differential early development of brain appetite circuits, which in turn gives rise to variation in appetitive behaviors and behaviors involving reward processing and cognitive control as well as altered function of brain appetite circuits, that act to influence the development of obesity into middle childhood. The investigator's long-term goal is to lay foundations for developmentally-appropriate, neurobehaviorally-informed interventions to address child obesity.

Вмешательства

  • Другое fMRI cue reactivity task
    Measures effect of food and non-food cues on brain activation
  • Другое fMRI go no go task
    Measures effect of food and non-food cues on inhibitory responses and brain activation
  • Другое Ad libitum meal test
    Measures effect of exposure to multi-item buffet meal on food intake
  • Другое Eating in the absence of hunger test
    Measures effect of exposure to palatable snacks on food intake

Первичные конечные точки

  • Meal test intake as assessed by total kilocalories consumed [Срок оценки: Day 1]
  • Weight/adiposity as assessed by BMI [Срок оценки: Day 1]
  • Food-related reward as assessed by food-related delay discounting task [Срок оценки: Day 1]
  • Food-related cognitive control as assessed by food-related go/no-go task [Срок оценки: Day 1]
  • Functioning in brain appetite circuits as assessed by cue reactivity task [Срок оценки: During MRI procedure]
  • Functioning in brain appetite circuits as assessed by cognitive control task [Срок оценки: During MRI procedure]

Критерии участия

Критерии включения

  • Participants from the RESONANCE cohort are eligible if the participant will reach 7-12 years of age during the proposed project period and have no food allergies.

Критерии исключения

  • Exclusion criteria for RESONANCE include:
  • In utero exposure to alcohol, cigarette, or illicit substances;
  • First trimester fetal US abnormalities;
  • Complicated pregnancy (e.g., pre-eclampsia);
  • Complicated delivery, including APGAR scores less than 8 and/or neonatal intensive care unit (NICU) admission;
  • History of neurological (e.g., epilepsy), psychiatric (e.g., anxiety or depression requiring treatment with medication) or developmental disorder (e.g., autism spectrum disorder (ASD), dyslexia);
  • Contraindications for MRI including metal in the body, claustrophobia.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Фундаментальное исследование

Центры проведения

США · 4 центра
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc. — Baltimore
  • Johns Hopkins University School of Medicine — Baltimore
  • Rhode Island Hospital — Providence
  • University of Washington — Seattle

Идентификаторы

NCT: NCT06861868 · IRB00118376 · R01DK136602

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗